Stephen Chan Ph.D.

Tybourne Capital Management is an Asia-based global growth investor with a fundamental approach to equity investing across public and private markets. We invest for the long term to manage through cycles and focus on delivering exceptional compound returns for our investors over time. We manage assets on behalf of endowments, institutions, sovereign wealth funds, charitable organizations and family offices. Tybourne has approximately 30 employees and offices in Hong Kong and San Francisco.

A global leader in Healthcare and Life sciences expert connections, Techspert connects the right people and insights together, through our award-winning platform. We combine our unique search technology with our hugely talented international team in Cambridge UK, and Houston US, to deliver the highest quality and most precisely matched expert connections.

Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem

Tybourne Capital Management is an Asia-based global growth investor with a fundamental approach to equity investing across public and private markets. We invest for the long term to manage through cycles and focus on delivering exceptional compound returns for our investors over time. We manage assets on behalf of endowments, institutions, sovereign wealth funds, charitable organizations and family offices. Tybourne has approximately 30 employees and offices in Hong Kong and San Francisco.

A global leader in Healthcare and Life sciences expert connections, Techspert connects the right people and insights together, through our award-winning platform. We combine our unique search technology with our hugely talented international team in Cambridge UK, and Houston US, to deliver the highest quality and most precisely matched expert connections.

Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem

Atlantis is an Asian equity dedicated asset management company. The firm was founded in London in 1994 by three star ex-Schroders fund managers and remains 100% owner managed. Since inception, Atlantis has been dedicated exclusively to Asian equity strategies. Our two main investment focuses, China and Asia, are operated independently and led by our dedicated portfolio managers. While the non-investment functions (risk management, legal and compliance, trading, operations, marketing and investor relations) are provided from Hong Kong, our investment and research professionals are based regionally in Asia – Hong Kong, Shanghai and Singapore. This enables our investment professionals to focus on what they do best and provide us our key advantages: local, street-level intelligence. Atlantis currently offers a wide range of services for global institutional investors through the Atlantis funds and via segregated mandates.